BioAtla Funding: $73M Raised, Series D (2020)

BioAtla funding overview

BioAtla is based in San Diego. BioAtla has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series D announced in July 2020. The round record for BioAtla runs through 2020; nothing later has been disclosed. Investors on record include Soleus Capital, HBM Healthcare Investments, Cormorant Asset Management, Farallon Capital, Pappas Capital, Janus Henderson and 2 others. 8 distinct backers are named across the disclosed rounds.

BioAtla at a glance

Total raised: $73M
Latest round: Series D
Latest round date: July 2020
Headquarters: San Diego
Notable investors: Soleus Capital, HBM Healthcare Investments, Cormorant Asset Management, Farallon Capital, Pappas Capital, Janus Henderson, Boxer Capital, Pfizer Ventures

Frequently asked about BioAtla funding

How much has BioAtla raised?: BioAtla has raised $73M in total disclosed funding across the rounds on record.
Who has invested in BioAtla?: Soleus Capital, HBM Healthcare Investments, Cormorant Asset Management, Farallon Capital, Pappas Capital, Janus Henderson are named among the investors backing BioAtla.
What was the latest BioAtla funding round?: The most recent disclosed round is a Series D, announced in July 2020.
Where is BioAtla based?: BioAtla is based in San Diego.
When did BioAtla last raise?: The last disclosed BioAtla round closed in July 2020 at Series D.

BioAtla totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in San Diego below to benchmark round size and investor mix.

BioAtla Funding: $73M Raised, Series D (2020)

BioAtla funding overview

BioAtla at a glance

Frequently asked about BioAtla funding

Companies related to BioAtla (30)

Browse related funding lists (10)